A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Main Author: | Islam, Nahidul |
|---|---|
| Other Authors: | Talukder, Mesbah |
| Format: | Thesis |
| Language: | English |
| Published: |
Brac University
2023
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10361/22025 |
Similar Items
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
by: Afroza, Halima
Published: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
by: Moya, Amena Khatun
Published: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
by: Bishakha, Adwiza Chakraborty
Published: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
by: Islam, S.M. Zahidul
Published: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
by: Khandker, Tahia Anjum
Published: (2024)